| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000034613 |
| Receipt No. | R000039464 |
| Official scientific title of the study | The Exploratory Study about Efficacy and Safety of Ninjin'yoeito for Fatigue and Malaise Expressed in Postoperative Patients with Colorectal Cancer |
| Date of disclosure of the study information | 2018/11/15 |
| Last modified on | 2018/10/24 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The Exploratory Study about Efficacy and Safety of Ninjin'yoeito for Fatigue and Malaise Expressed in Postoperative Patients with Colorectal Cancer | |
| Title of the study (Brief title) | The Exploratory Study about Efficacy and Safety of Ninjin'yoeito in Postoperative Patients with Colorectal Cancer | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the efficacy and safety of Ninjin'yoeito for fatigue and malaise expressed in postoperative elderly patients with colorectal cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fatigue and Malaise: The Evaluation by Chaludder fatigue questionnaire |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The administration of Ninjin'yoeito | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with resected colorectal cancer (clinical stage I to IIIb)
2) Patients with Grade 1 or higherfatigue or malaise after surgery (CTCAE ver. 4.0) 3) Patients with ECOG PS 0 to 2 4) Patients whose main organ functions are adequately maintained 5) Age: over 80 years old (when acquiring consent) 6) Category of examination: Outpatient and hospitalization 7) Patients who can be orally administered 8) Patients who wrote consent form to participate in this study |
|||
| Key exclusion criteria | 1) Patients with active other cancers
2) Patients with severe complications (such as liver disease, renal disease, heart disease, blood disease or metabolic disease) or mental disease 3) Patients taking drugs banned in this study or Ninjin'yoeito within 4 weeks before the start of the study 4) Patients who have a history of allergies to traditional Chinese medicine |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Fujii Tsutomu |
| Organization | Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama |
| Division name | Department of Surgery and Science |
| Address | 2630, Sugitani, Toyama |
| TEL | 076-434-7331 |
| surgery2@med.u-toyama.ac.jp | |
| Public contact | |
| Name of contact person | Baba Hayato |
| Organization | Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama |
| Division name | Department of Surgery and Science |
| Address | 2630, Sugitani, Toyama |
| TEL | 076-434-7331 |
| Homepage URL | |
| hayato.bb@gmail.com | |
| Sponsor | |
| Institute | University of Toyama |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Toyama |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039464 |